Financials

News Ideas Discussions Technicals Forecast Seasonals

XBRANE fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Xbrane Biopharma AB is a biopharmaceutical company, which engages in the development and manufacture of biosimilars. Its products include Ximluci, BIIB801, Xdivane, Xtrudane, and Xdarzane. The company was founded by Jan-Willem de Gier, Marten Hellberg, and Samuel Wagner in 2008 and is headquartered in Solna, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

XBRANE has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company